These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 24156826)
1. Relieving the cardiometabolic disease burden: a perspective on phytometabolite functional and chemical annotation for diabetes management. Janero DR Expert Opin Pharmacother; 2014 Jan; 15(1):5-10. PubMed ID: 24156826 [TBL] [Abstract][Full Text] [Related]
2. Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. Yang WS; Wang WY; Fan WY; Deng Q; Wang X Br J Nutr; 2014 Apr; 111(8):1329-39. PubMed ID: 24331002 [TBL] [Abstract][Full Text] [Related]
3. Phytochemicals: the future of radiation induced mucositis prevention. Basu T; Laskar SG; Gupta T; Budrukkar A; Murthy V; Agarwal JP J Cancer Res Ther; 2013; 9(4):761-762. PubMed ID: 24669414 [No Abstract] [Full Text] [Related]
4. A qualitative exploration of multiple medicines beliefs in co-morbid diabetes and cardiovascular disease. Stack RJ; Elliott RA; Noyce PR; Bundy C Diabet Med; 2008 Oct; 25(10):1204-10. PubMed ID: 19046199 [TBL] [Abstract][Full Text] [Related]
5. Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in type 2 diabetes. Ross SA; Ballantine J Curr Med Res Opin; 2013 Dec; 29(12):1617-26. PubMed ID: 23971789 [TBL] [Abstract][Full Text] [Related]
6. [On some pathogenic features of diabetic retinopathy in type II diabetes mellitus and the role of antioxidants and ginkgo biloba]. Alekseev IB; Kochergin SA; Vorob'eva IV; Mikhaleva LG Vestn Oftalmol; 2013; 129(3):89-93. PubMed ID: 23879031 [TBL] [Abstract][Full Text] [Related]
8. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020. Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836 [TBL] [Abstract][Full Text] [Related]
9. Mining of protein based biomarkers for type 2 diabetes mellitus. Khan AR; Awan FR Pak J Pharm Sci; 2012 Oct; 25(4):889-901. PubMed ID: 23010011 [TBL] [Abstract][Full Text] [Related]
10. Controversies surrounding the clinical potential of cinnamon for the management of diabetes. Rafehi H; Ververis K; Karagiannis TC Diabetes Obes Metab; 2012 Jun; 14(6):493-9. PubMed ID: 22093965 [TBL] [Abstract][Full Text] [Related]
12. Use of natural products in gastrointestinal therapies. Brierley SM; Kelber O Curr Opin Pharmacol; 2011 Dec; 11(6):604-11. PubMed ID: 21996284 [TBL] [Abstract][Full Text] [Related]
13. [Erection help from the rain forest?]. Praxis (Bern 1994); 2004 Aug; 93(33):1326. PubMed ID: 15453437 [No Abstract] [Full Text] [Related]
14. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Wang M; Lamers RJ; Korthout HA; van Nesselrooij JH; Witkamp RF; van der Heijden R; Voshol PJ; Havekes LM; Verpoorte R; van der Greef J Phytother Res; 2005 Mar; 19(3):173-82. PubMed ID: 15934013 [TBL] [Abstract][Full Text] [Related]
15. Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes. Blevins SM; Leyva MJ; Brown J; Wright J; Scofield RH; Aston CE Diabetes Care; 2007 Sep; 30(9):2236-7. PubMed ID: 17563345 [No Abstract] [Full Text] [Related]
16. [Clinical phytotherapy: opportunities and problematics]. Firenzuoli F; Gori L; Neri D Ann Ist Super Sanita; 2005; 41(1):27-33. PubMed ID: 16037646 [TBL] [Abstract][Full Text] [Related]
17. Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification. McCarthy MI Hum Mol Genet; 2004 Apr; 13 Spec No 1():R33-41. PubMed ID: 14722160 [TBL] [Abstract][Full Text] [Related]
18. Nutraceuticals and Diet-based Phytochemicals in Type 2 Diabetes Mellitus: From Whole Food to Components with Defined Roles and Mechanisms. Onaolapo AY; Onaolapo OJ Curr Diabetes Rev; 2019; 16(1):12-25. PubMed ID: 30378500 [TBL] [Abstract][Full Text] [Related]
19. Intensified multifactorial treatment of patients with Type 2 diabetes: what can be achieved and does it pay off? Pedersen O J Diabetes; 2009 Jun; 1(2):83-9. PubMed ID: 20929504 [TBL] [Abstract][Full Text] [Related]
20. What is the best strategy for preclinical testing of botanicals? A critical perspective. Butterweck V; Nahrstedt A Planta Med; 2012 May; 78(8):747-54. PubMed ID: 22499562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]